Vesalius Biocapital Partners
Venture capitalLuxembourg · Seed–Late Stage · 5 people tracked
Investment thesis
The firm invests in the life sciences, backing both early-stage companies and corporate spin-offs holding more mature assets. It draws on deep scientific knowledge, investment experience, and a company-building mindset to support ambitious entrepreneurs. Beyond capital, it helps optimize business plans, provides introductions to other venture investors and leading global healthcare companies, assists with recruiting talent, and supports exit planning. Investments are made progressively across multiple financing rounds, with commitments of up to €10 million per portfolio company, though smaller seed investments of a few hundred thousand euros are also possible. As active investors, the firm leads or co-leads rounds and always takes a board seat.
Source: firm website, verified Aug 3, 2026.
Team · 5 people
from the firm's websiteFrequently asked questions
- What stage does Vesalius Biocapital Partners invest at?
- Vesalius Biocapital Partners invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What is Vesalius Biocapital Partners's typical check size?
- Vesalius Biocapital Partners typically writes checks of $11M.
- What sectors does Vesalius Biocapital Partners focus on?
- Vesalius Biocapital Partners focuses on Biotech, Digital Health, FoodTech, Healthtech, Medical Devices.
- Where is Vesalius Biocapital Partners located?
- Vesalius Biocapital Partners is headquartered in Luxembourg, LU.
- Does Vesalius Biocapital Partners lead rounds?
- Yes, Vesalius Biocapital Partners leads investment rounds.
Media · Podcasts & interviews
featuring the teamThe Value Creators with Fabienne Roussel & Guy Geldhof (Vesalius Biocapital Partners) - YouTube
LPEA Luxembourg · Guy Geldhof
Similar investors
DCVC (Data Collective) is a deep tech venture capital firm backing entrepreneurs using computational approaches to solve large real-world problems across many industries. It operates six flagship funds plus DCVC Bio, spanning 13 funds to date.
Seventure Partners is a European venture capital firm investing across life sciences, digital technologies, sport and performance, and the blue economy.
Obvious is a venture capital firm focused on supporting founders building solutions to humanity's largest challenges across planetary health, human health, and economic health.
Redalpine is a European venture capital firm that funds and supports technology-driven startups based in Europe with global ambitions.
Amadeus Capital Partners is a technology investor. It held a first close of $75M on its Amadeus IV Digital Prosperity Fund, focused on late-stage venture and growth companies building online and mobile services for emerging-market middle classes.